• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-三氟甲基查耳酮作为潜在的雄激素受体非依赖性前列腺癌抗癌剂。

α-Trifluoromethyl Chalcones as Potent Anticancer Agents for Androgen Receptor-Independent Prostate Cancer.

机构信息

School of Pharmaceutical Sciences, College of Medical, Pharmaceutical and Health Science, Kanazawa University, Kanazawa 920-1192, Japan.

Department of Integrative Cancer Therapy and Urology, School of Medical Sciences, Kanazawa University, Kanazawa 920-1192, Japan.

出版信息

Molecules. 2021 May 10;26(9):2812. doi: 10.3390/molecules26092812.

DOI:10.3390/molecules26092812
PMID:34068627
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8126091/
Abstract

α-Trifluoromethyl chalcones were prepared and evaluated for their antiproliferative activities against androgen-independent prostate cancer cell lines as well as five additional types of human tumor cell lines. The most potent chalcone showed superior antitumor activity in vivo with both oral and intraperitoneal administration at 3 mg/kg. Cell-based mechanism of action studies demonstrated that induced cell accumulation at sub-G1 and G2/M phases without interfering with microtubule polymerization. Furthermore, several cancer cell growth-related proteins were identified by using chalcone as a bait for the affinity purification of binding proteins.

摘要

α-三氟甲基查耳酮被制备并评价其对雄激素非依赖性前列腺癌细胞系以及另外五种人类肿瘤细胞系的抗增殖活性。最有效的查尔酮在 3mg/kg 的口服和腹腔内给药时在体内显示出优越的抗肿瘤活性。基于细胞的作用机制研究表明, 诱导细胞在 sub-G1 和 G2/M 期积累,而不干扰微管聚合。此外,使用查尔酮作为结合蛋白亲和纯化的诱饵,鉴定了几种与癌细胞生长相关的蛋白质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42eb/8126091/b2be54c42760/molecules-26-02812-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42eb/8126091/38588525cced/molecules-26-02812-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42eb/8126091/4d0eeebfec5f/molecules-26-02812-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42eb/8126091/7c6c2ed60c92/molecules-26-02812-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42eb/8126091/dfbfb7ff45cf/molecules-26-02812-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42eb/8126091/b2be54c42760/molecules-26-02812-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42eb/8126091/38588525cced/molecules-26-02812-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42eb/8126091/4d0eeebfec5f/molecules-26-02812-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42eb/8126091/7c6c2ed60c92/molecules-26-02812-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42eb/8126091/dfbfb7ff45cf/molecules-26-02812-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42eb/8126091/b2be54c42760/molecules-26-02812-g003.jpg

相似文献

1
α-Trifluoromethyl Chalcones as Potent Anticancer Agents for Androgen Receptor-Independent Prostate Cancer.α-三氟甲基查耳酮作为潜在的雄激素受体非依赖性前列腺癌抗癌剂。
Molecules. 2021 May 10;26(9):2812. doi: 10.3390/molecules26092812.
2
5'-Chloro-2,2'-dihydroxychalcone and related flavanoids as treatments for prostate cancer.5'-氯-2,2'-二羟基查尔酮及相关黄烷类化合物治疗前列腺癌的研究进展。
Eur J Med Chem. 2018 Sep 5;157:1143-1152. doi: 10.1016/j.ejmech.2018.08.069. Epub 2018 Aug 28.
3
Novel α-Trifluoromethyl Chalcone Exerts Antitumor Effects Against Prostate Cancer Cells.新型α-三氟甲基查尔酮对前列腺癌细胞具有抗肿瘤作用。
Anticancer Res. 2023 Jun;43(6):2433-2444. doi: 10.21873/anticanres.16411.
4
Relaxin receptor antagonist AT-001 synergizes with docetaxel in androgen-independent prostate xenografts.松弛素受体拮抗剂 AT-001 与多西他赛在雄激素非依赖性前列腺异种移植中协同作用。
Endocr Relat Cancer. 2014 May 8;21(3):459-71. doi: 10.1530/ERC-14-0088. Print 2014 Jun.
5
New 4-maleamic acid and 4-maleamide peptidyl chalcones as potential multitarget drugs for human prostate cancer.新型 4-脒基酸和 4-脒基肽查耳酮作为治疗人类前列腺癌的多靶药物。
Pharm Res. 2011 Apr;28(4):907-19. doi: 10.1007/s11095-010-0347-8. Epub 2010 Dec 24.
6
Syntheses and potential anti-prostate cancer activities of ionone-based chalcones.基于紫罗兰酮的查耳酮的合成及其潜在的抗前列腺癌活性。
Bioorg Med Chem Lett. 2009 Feb 15;19(4):1183-6. doi: 10.1016/j.bmcl.2008.12.089. Epub 2008 Dec 25.
7
A new flavonoid derivative exerts antitumor effects against androgen-sensitive to cabazitaxel-resistant prostate cancer cells.一种新型黄酮类衍生物对雄激素敏感至卡巴他赛耐药的前列腺癌细胞具有抗肿瘤作用。
Prostate. 2021 Apr;81(5):295-306. doi: 10.1002/pros.24106. Epub 2021 Jan 25.
8
Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.查耳酮的抗有丝分裂和抗增殖活性:正向构效关系。
J Med Chem. 2008 Apr 10;51(7):2307-10. doi: 10.1021/jm0708331. Epub 2008 Feb 23.
9
Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin.使用HTI-286靶向前列腺癌,HTI-286是海洋海绵产物半枝星菌素的一种合成类似物。
Int J Cancer. 2008 May 15;122(10):2368-76. doi: 10.1002/ijc.23406.
10
Luteinizing hormone-releasing hormone receptor-targeted deslorelin-docetaxel conjugate enhances efficacy of docetaxel in prostate cancer therapy.靶向促黄体生成素释放激素受体的地洛瑞林-多西他赛共轭物增强多西他赛在前列腺癌治疗中的疗效。
Mol Cancer Ther. 2009 Jun;8(6):1655-65. doi: 10.1158/1535-7163.MCT-08-0988. Epub 2009 Jun 9.

引用本文的文献

1
Impact of trifluoromethyl Ugi adducts as anticancer agents: EGFR inhibition, apoptosis induction and miRNA up-regulation.三氟甲基乌吉加成物作为抗癌剂的影响:表皮生长因子受体抑制、细胞凋亡诱导和微小核糖核酸上调
RSC Adv. 2025 Jun 10;15(24):19530-19545. doi: 10.1039/d5ra01428j. eCollection 2025 Jun 4.
2
Potential of Synthetic and Natural Compounds as Novel Histone Deacetylase Inhibitors for the Treatment of Hematological Malignancies.合成与天然化合物作为新型组蛋白去乙酰化酶抑制剂治疗血液系统恶性肿瘤的潜力
Cancers (Basel). 2023 May 17;15(10):2808. doi: 10.3390/cancers15102808.
3
Identification of novel non-toxic and anti-angiogenic α-fluorinated chalcones as potent colchicine binding site inhibitors.

本文引用的文献

1
Effects of substituent pattern on the intracellular target of antiproliferative benzo[b]thiophenyl chromone derivatives.取代模式对具有抗增殖作用的苯并[b]噻吩色酮衍生物细胞内靶点的影响。
Eur J Med Chem. 2021 Oct 15;222:113578. doi: 10.1016/j.ejmech.2021.113578. Epub 2021 May 25.
2
Bicyclic Chalcones as Mitotic Inhibitors for Overcoming Androgen Receptor-Independent and Multidrug-Resistant Prostate Cancer.双环查耳酮作为有丝分裂抑制剂用于克服雄激素受体非依赖性和多药耐药性前列腺癌
ACS Omega. 2021 Feb 9;6(7):4842-4849. doi: 10.1021/acsomega.0c05822. eCollection 2021 Feb 23.
3
A new flavonoid derivative exerts antitumor effects against androgen-sensitive to cabazitaxel-resistant prostate cancer cells.
鉴定新型无毒、抗血管生成的α-氟查耳酮类化合物作为强力秋水仙碱结合位点抑制剂。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):339-354. doi: 10.1080/14756366.2021.2014831.
一种新型黄酮类衍生物对雄激素敏感至卡巴他赛耐药的前列腺癌细胞具有抗肿瘤作用。
Prostate. 2021 Apr;81(5):295-306. doi: 10.1002/pros.24106. Epub 2021 Jan 25.
4
A structural view of PA2G4 isoforms with opposing functions in cancer.具有相反功能的 PA2G4 异构体在癌症中的结构观点。
J Biol Chem. 2020 Nov 20;295(47):16100-16112. doi: 10.1074/jbc.REV120.014293. Epub 2020 Sep 20.
5
5'-Chloro-2,2'-dihydroxychalcone and related flavanoids as treatments for prostate cancer.5'-氯-2,2'-二羟基查尔酮及相关黄烷类化合物治疗前列腺癌的研究进展。
Eur J Med Chem. 2018 Sep 5;157:1143-1152. doi: 10.1016/j.ejmech.2018.08.069. Epub 2018 Aug 28.
6
Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines.两种卡巴他赛耐药前列腺癌细胞系的建立与鉴定
Oncotarget. 2018 Mar 5;9(22):16185-16196. doi: 10.18632/oncotarget.24609. eCollection 2018 Mar 23.
7
Conformational mimetics of the α-methyl chalcone TUB091 binding tubulin: Design, synthesis and antiproliferative activity.α-甲基查尔酮 TUB091 结合微管蛋白的构象模拟物:设计、合成与抗增殖活性。
Eur J Med Chem. 2018 Mar 25;148:337-348. doi: 10.1016/j.ejmech.2018.02.019. Epub 2018 Feb 10.
8
PINK1 Phosphorylates MIC60/Mitofilin to Control Structural Plasticity of Mitochondrial Crista Junctions.PINK1 通过磷酸化 MIC60/肌球蛋白 60 来控制线粒体嵴连接的结构可塑性。
Mol Cell. 2018 Mar 1;69(5):744-756.e6. doi: 10.1016/j.molcel.2018.01.026. Epub 2018 Feb 15.
9
Chalcone: A Privileged Structure in Medicinal Chemistry.查尔酮:药物化学中的一种优势结构。
Chem Rev. 2017 Jun 28;117(12):7762-7810. doi: 10.1021/acs.chemrev.7b00020. Epub 2017 May 10.
10
Heat Shock Proteins and Cancer.热休克蛋白与癌症。
Trends Pharmacol Sci. 2017 Mar;38(3):226-256. doi: 10.1016/j.tips.2016.11.009. Epub 2016 Dec 22.